Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Could scorpion venom inspire new treatments for liver disease?

8

Sep 2026

Could scorpion venom inspire new treatments for liver disease?

Scorpion venom peptides show promising anti-inflammatory, antiviral, analgesic, and immunomodulatory effects, with experimental evidence suggesting that some candidates could target pathways involved in chronic liver disease and viral hepatitis. The review highlights Kv1.3-blocking peptides and antiviral compounds as potential therapeutic leads, while emphasizing that limited hepatic efficacy data, poor pharmacokinetics, immunogenicity, and manufacturing challenges must be overcome before clinical translation.

Why do older adults often feel better emotionally? Mindfulness may be part of the answer

8

Sep 2026

Why do older adults often feel better emotionally? Mindfulness may be part of the answer

In a cross-sectional U.S. sample of 129 adults, older age was associated with greater positive and lower negative emotional well-being, alongside greater dispositional mindfulness and lower neuroticism. Lower neuroticism statistically accounted for age differences in both positive and negative well-being, while mindfulness statistically accounted for differences in negative well-being only, although the study cannot establish causality.

Could one amino acid help explain why men tend to live shorter lives?

7

Sep 2026

Could one amino acid help explain why men tend to live shorter lives?

A UK Biobank cohort and Mendelian randomization study involving 272,475 participants linked higher circulating tyrosine with greater all-cause mortality and genetically predicted higher tyrosine with shorter lifespan. After accounting for phenylalanine, the relationship with shorter lifespan was clearest in men, while findings in women were less consistent, suggesting a potential sex-specific role for tyrosine in longevity.

Study reveals evolutionary advantage of human heel-first walking style

7

Sep 2026

Study reveals evolutionary advantage of human heel-first walking style

The average person takes thousands of steps each day, instinctively walking heel-to-toe. Although they hardly register them, those consistent heel-first strides are more unique to humans than previously thought and allowed early hominins to walk farther more efficiently, but at the cost of higher impact forces on bones and joints, according to a new study led by a researcher at Penn State.

The vaginal microbiome may be an overlooked reservoir of antibiotic resistance

7

Sep 2026

The vaginal microbiome may be an overlooked reservoir of antibiotic resistance

Researchers analyzed 1,957 vaginal metagenomic samples from 1,547 pregnant women and found that bacterial community structure was strongly associated with the diversity and distribution of clinically relevant antibiotic resistance genes. Lactobacillus crispatus-dominated communities carried comparatively few acquired resistance genes, while L. iners-dominated and anaerobe-rich communities showed greater resistance diversity, with PPROM associated with broader predicted resistance profiles among ARG-positive samples.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.